Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
DermTech, Inc. DMTK
$2.23
-$0.08 (-3.68%)
На 18:01, 12 мая 2023
+572.65%
Потенциал через год
Ранг: 3
Ключевые показатели
-
Marketcap
77947856.00000000
-
week52high
8.93
-
week52low
1.55
-
Revenue
14518000
-
P/E TTM
-1
-
Beta
2.54299200
-
EPS
-3.74000000
-
Last Dividend
0.00000000
-
Next Earnings Date
04 мая 2023 г. в 20:00
Описание компании
DermTech, Inc., a molecular diagnostic company, develops and markets novel non-invasive genomics tests to diagnosis skin cancer, inflammatory diseases, and aging-related conditions in the United States. It offers DermTech Melanoma Test (DMT), a gene expression test that enhances early detection of genomic atypia and helps rule out melanoma and the need for a surgical biopsy of atypical pigmented lesions. The company also provides adhesive skin sample collection kits, as well as gene expression assays for the Th1, Th2, IFN-gamma, and Th17 inflammatory pathways. In addition, it is developing UV damage DNA risk assessment products, as well as non-melanoma skin cancer diagnostic and cutaneous T-cell lymphoma rule out test products, as well as offering health-related and information services through electronic information and telecommunication technologies. The company sells its products primarily to pathology and oncology practitioners. DermTech, Inc. is headquartered in La Jolla, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Oppenheimer | Outperform | Outperform | 17 авг 2022 г. |
| BTIG | Buy | Buy | 15 авг 2022 г. |
| Stephens & Co. | Overweight | 07 янв 2022 г. | |
| BTIG | Buy | 03 мая 2021 г. | |
| Oppenheimer | Outperform | 22 янв 2021 г. | |
| William Blair | Market Perform | Outperform | 04 ноя 2022 г. |
| Stephens & Co. | Overweight | Overweight | 09 ноя 2022 г. |
| BTIG | Buy | Buy | 08 ноя 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| Akhavan Ramin | D | 89707 | 3186 | 05 янв 2023 г. |
| Ibarra Claudia | D | 157822 | 328 | 12 дек 2022 г. |
| Wood Todd Michael | D | 214110 | 356 | 12 дек 2022 г. |
| Ibarra Claudia | D | 158150 | 2496 | 08 дек 2022 г. |
| Wood Todd Michael | D | 214466 | 448 | 08 дек 2022 г. |
| Ibarra Claudia | D | 160646 | 137 | 06 дек 2022 г. |
| Wood Todd Michael | D | 214914 | 185 | 06 дек 2022 г. |
| RTW INVESTMENTS, LP | D | 3018666 | 100000 | 04 ноя 2022 г. |
| Ibarra Claudia | D | 160783 | 322 | 12 сент 2022 г. |
| Wood Todd Michael | D | 215099 | 350 | 12 сент 2022 г. |
Новостная лента
DermTech, Inc. (DMTK) Reports Q1 Loss, Lags Revenue Estimates
Zacks Investment Research
04 мая 2023 г. в 19:01
DermTech, Inc. (DMTK) came out with a quarterly loss of $1.02 per share versus the Zacks Consensus Estimate of a loss of $0.90. This compares to loss of $1.01 per share a year ago.
DermTech to Present at March Investor Conferences
Business Wire
03 мар 2023 г. в 08:05
LA JOLLA, Calif.--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced that management is scheduled to present at the following investor conferences during March 2023. TD Cowen 43rd Annual Health Care Conference, Boston – fireside chat on March 8, 2023 at 1:30 p.m. ET. Oppenheimer 33rd Annual Healthcare Conference, Virtual – presentation on March 14, 2023 at 10:00 a.m.
DermTech, Inc. (DMTK) Q4 2022 Earnings Call Transcript
Seeking Alpha
02 мар 2023 г. в 20:51
DermTech, Inc. (NASDAQ:DMTK ) Q4 2022 Earnings Conference Call March 2, 2023 5:00 PM ET Company Participants Steve Kunszabo - Head of IR John Dobak - President and CEO Kevin Sun - CFO Conference Call Participants Thomas Flaten - Lake Street Capital Stephanie Yan - Cowen Mark Massaro - BTIG Francois Brisebois - Oppenheimer Andrew Brackmann - William Blair Jacob Johnson - Stephens Operator Good day and thank you for standing by. Welcome to DermTech's Fourth Quarter 2022 Financial Results Conference Call.
DermTech, Inc. (DMTK) Reports Q4 Loss, Tops Revenue Estimates
Zacks Investment Research
02 мар 2023 г. в 18:49
DermTech, Inc. (DMTK) delivered earnings and revenue surprises of 3.12% and 19.52%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
DermTech Announces Release Date for Fourth-Quarter 2022 Financial Results
Business Wire
10 февр 2023 г. в 08:30
LA JOLLA, Calif.--(BUSINESS WIRE)--DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, will host a conference call and webcast on Thursday, March 2, 2023 at 5:00 p.m. Eastern Time (ET) to discuss the Company's fourth-quarter 2022 operating and financial results. In advance of the call on March 2, 2023, DermTech will issue its fourth-quarter 2022 earnings press release.